Related Experiment Videos
Ovarian suppression and breast cancer
The Surgical Clinics of North America
|August 1, 1978
Summary
Castration, using radiation or surgery, can regress breast cancer metastasis in patients with high estrophile protein levels. Prophylactic castration may delay recurrence, reducing new breast cancer incidence over time.
Area of Science:
- Oncology
- Endocrinology
Background:
- Estrophile protein concentration in breast tissue is a key indicator for treatment efficacy.
- Castration, through radiation or oophorectomy, is a recognized method for managing breast cancer metastasis.
Purpose of the Study:
- To evaluate the efficacy of castration as an early adjunctive therapy for breast cancer.
- To determine the long-term impact of prophylactic castration on recurrence and incidence of new breast cancers.
Main Methods:
- Castration achieved via radiation or surgery.
- Analysis of patient data considering estrophile protein levels.
- Long-term follow-up (10-20 years) to assess recurrence and incidence.
Main Results:
- Castration can lead to regression of tumor metastasis, particularly in patients with high estrophile protein.
- Prophylactic castration shows potential in delaying recurrence onset.
- Premenopausal castration may significantly decrease the incidence of new breast cancers over extended periods.
Conclusions:
- Castration is an effective treatment for breast cancer metastasis and can be considered for prophylactic use.
- Patient selection based on estrophile protein levels is crucial for optimal outcomes.
- Long-term studies indicate a benefit of prophylactic castration in reducing breast cancer incidence.